文献速递泌尿生殖技术与安全CT

静脉水化对eGFR低于30 mL/min/1.73 m²患者静脉注射碘对比剂后预防对比剂后急性肾损伤的效果

Effects of intravenous hydration in preventing post-contrast acute kidney injury in patients with eGFR < 30 mL/min/1.73 m2.
PubMed 文献 · Eur Radiol · 2023-06-27

纳入2015至2021年住院且eGFR<30 mL/min/1.73 m²并接受静脉碘对比剂暴露的患者794例,其中284例接受静脉水化、510例未接受。倾向评分匹配后210对分析显示,静脉水化与未水化组在KDIGO或ESUR定义的对比剂后急性肾损伤、出院时慢性透析及院内死亡方面均无显著差异。

要点

  • eGFR<30 mL/min/1.73 m²患者静脉用碘对比剂前后行静脉水化,未降低对比剂后急性肾损伤风险。
  • 匹配后KDIGO定义对比剂后急性肾损伤水化组25.2% vs 未水化组24.8%(OR 0.93,95%CI 0.57-1.50)。
  • 作者提出,此类患者围静脉用碘对比剂期可考虑不进行静脉水化。

核心结论

  • 在eGFR<30 mL/min/1.73 m²并接受静脉碘对比剂的患者中,静脉水化与对比剂后急性肾损伤、出院时慢性透析及院内死亡风险降低无关。

研究设计与样本

  • 研究纳入2015至2021年住院、eGFR<30 mL/min/1.73 m²且接受静脉碘对比剂暴露的患者794例,其中284例接受静脉水化、510例未接受;采用倾向评分匹配(1:1匹配后210对)和重叠权重分析,以logistic回归分析水化与结局的关联。

诊断标准与关键数值

  • 对比剂后急性肾损伤分别按2012年KDIGO标准或ESUR标准定义;匹配后KDIGO定义对比剂后急性肾损伤水化组25.2% vs 未水化组24.8%(OR 0.93,95%CI 0.57-1.50);ESUR定义水化组31.0% vs 未水化组25.2%(OR 1.34,95%CI 0.86-2.08)。

临床应用与阅片要点

  • 作者认为,对于eGFR<30 mL/min/1.73 m²并围静脉用碘对比剂期的患者,可考虑不进行静脉水化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the effects of intravenous hydration in preventing post-contrast outcomes in patients with estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 undergoing intravenous administration of iodinated contrast media (ICM).

METHODS: Hospitalized patients with eGFR < 30 mL/min/1.73 m2 and intravenous ICM exposure between 2015 and 2021 were included. Post-contrast outcomes include post-contrast acute kidney injury (PC-AKI) (defined by 2012 Kidney Disease: Improving Global Outcomes (KDIGO) or European Society of Urogenital Radiology (ESUR)), chronic dialysis at discharge, and in-hospital mortality. Confounding effects between the two groups were reduced to a minimum using propensity score-based matching and overlap weighting. Association between intravenous hydration and outcomes was analyzed using logistic regression.

RESULTS: In total, 794 patients were included in the study, with 284 receiving intravenous hydration, and 510 not. After 1:1 propensity score matching, 210 pairs were generated. No significant differences were found in the outcomes between the intravenous hydration and no intravenous hydration groups: PC-AKI by KDIGO, 25.2% vs 24.8% (odds ratio (OR), 0.93; 95% confidence interval (CI), 0.57-1.50); PC-AKI by ESUR, 31.0% vs 25.2% (OR, 1.34; 95% CI, 0.86-2.08); chronic dialysis at discharge, 4.3% vs 3.3% (OR, 1.56; 95% CI, 0.56-4.50); in-hospital mortality, 1.9% vs 0.5% (OR, 4.08; 95% CI, 0.58-81.08). Overlap propensity score-weighted analysis also showed no significant effects of intravenous hydration on the incidences of the post-contrast outcomes.

CONCLUSIONS: Intravenous hydration was not associated with lower risks of PC-AKI, chronic dialysis at discharge, and in-hospital mortality in patients with eGFR < 30 mL/min/1.73 m2 undergoing intravenous administration of ICM.

CLINICAL RELEVANCE STATEMENT: This study provides new evidence in supporting that intravenous hydration is not beneficial to patients with eGFR < 30 mL/min/1.73 m2 before and after intravenous administration of iodinated contrast media.

KEY POINTS: • Intravenous hydration before and after intravenous administration of ICM is not associated with lower risks in PC-AKI, chronic dialysis at discharge, and in-hospital mortality in patients with eGFR < 30 mL/min/1.73 m2. • Withholding intravenous hydration may be considered in patients with eGFR < 30 mL/min/1.73 m2 around intravenous administration of ICM.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yan, Duan, Luo, et al. Effects of intravenous hydration in preventing post-contrast acute kidney injury in patients with eGFR < 30 mL/min/1.73 m2. Eur Radiol. 2023. PMID: 37368109. doi:10.1007/s00330-023-09858-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。